Health Care & Life Sciences » Biotechnology | Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. | Key People and Executives

Rostislav C. Raykov
Chief Executive Officer & Director
Khalid Islam
Chairman
Marco Maria Brughera
Independent Director
Adrian J. Haigh
Independent Director
Chris A. Rallis
Independent Director
Rostislav C. Raykov
Chief Executive Officer & Director
Robert C. Andrade
Chief Financial Officer
Mark Gowland
Controller
Khalid Islam
Chairman
Marco Maria Brughera
Independent Director
Adrian J. Haigh
Independent Director
Chris A. Rallis
Independent Director

About Fennec Pharmaceuticals

View Profile
Address
Research Triangle Park
Durham North Carolina 27709
United States
Employees -
Website http://www.fennecpharma.com
Updated 07/08/2019
Fennec Pharmaceuticals, Inc. is a small stage biotechnology company, which engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.